Abstract
Over the past several decades, many in vitro three-dimensional hepatocyte culture systems have been established, including collagen sandwiches, Matrigel™ cultures and microencapsulation systems. In addition, several studies have shown that materials with galactose ligands conjugated to their surfaces can improve hepatocyte attachment and allow the cells to maintain most of their functions. Pectin is a heterogeneous polymer of α-(1–4)-D-galacturonic acid with varying degrees of esterification and neutral sugar substitution and a variable molecular weight. In our work, we utilized pectin as a matrix to encapsulate hepatocytes. We evaluated the cellular functions of hepatocytes encapsulated in pectin and compared these functions with those of cells encapsulated in alginate. Based on the results of this work, we concluded that encapsulated HepG2 cells in pectin gel had a higher viability and superior urea synthesis function than cells in alginate microcapsules.
Keywords: Encapsulation, pectin, HepG2.
Micro and Nanosystems
Title:Evaluation of Pectin as a Material for Hepatocyte Encapsulation
Volume: 5 Issue: 2
Author(s): Shiao-Wen Tsai and Hau-Min Liou
Affiliation:
Keywords: Encapsulation, pectin, HepG2.
Abstract: Over the past several decades, many in vitro three-dimensional hepatocyte culture systems have been established, including collagen sandwiches, Matrigel™ cultures and microencapsulation systems. In addition, several studies have shown that materials with galactose ligands conjugated to their surfaces can improve hepatocyte attachment and allow the cells to maintain most of their functions. Pectin is a heterogeneous polymer of α-(1–4)-D-galacturonic acid with varying degrees of esterification and neutral sugar substitution and a variable molecular weight. In our work, we utilized pectin as a matrix to encapsulate hepatocytes. We evaluated the cellular functions of hepatocytes encapsulated in pectin and compared these functions with those of cells encapsulated in alginate. Based on the results of this work, we concluded that encapsulated HepG2 cells in pectin gel had a higher viability and superior urea synthesis function than cells in alginate microcapsules.
Export Options
About this article
Cite this article as:
Tsai Shiao-Wen and Liou Hau-Min, Evaluation of Pectin as a Material for Hepatocyte Encapsulation, Micro and Nanosystems 2013; 5(2) . https://dx.doi.org/10.2174/1876402911305020005
DOI https://dx.doi.org/10.2174/1876402911305020005 |
Print ISSN 1876-4029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1876-4037 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Challenging Treatment-Resistant Major Depressive Disorder: A Roadmap for Improved Therapeutics
Current Neuropharmacology Plasma Level of D-dimer is an Independent Diagnostic Biomarker for Deep Venous Thrombosis in Patients with Ischemic Stroke
Current Neurovascular Research Autoantibodies Profile in Matching CSF and Serum from AD and aMCI patients: Potential Pathogenic Role and Link to Oxidative Damage
Current Alzheimer Research Induction of Oral Tolerance with Transgenic Plants Expressing Antigens for Prevention/Treatment of Autoimmune, Allergic and Inflammatory Diseases
Current Pharmaceutical Biotechnology Novel Oral Anticoagulants in the Treatment of Acute Coronary Syndromes: Is there any Room for New Anticoagulants?
Current Clinical Pharmacology Inhibitory Activity of Curcumin Derivatives Towards Metal-Free and Metal-Induced Amyloid-β Aggregation
Current Alzheimer Research Recent Advances in Pharmacokinetics of Polymeric Excipients Used in Nanosized Anti-Cancer Drugs
Current Drug Metabolism Gadolinium-based Imaging Contrast Agents
Current Medical Imaging Involvement of Membrane Channels in Autoimmune Disorders
Current Pharmaceutical Design The Akt-mTOR Pathway in Down’s Syndrome: The Potential Use of Rapamycin/Rapalogs for Treating Cognitive Deficits
CNS & Neurological Disorders - Drug Targets ADAM Proteases: Protective Role in Alzheimers and Prion Diseases ?
Current Alzheimer Research Effect of Common NAT2 Variant Alleles in the Acetylation of the Major Clonazepam Metabolite, 7-minoclonazepam
Drug Metabolism Letters A Novel Botulinum Toxin TAT-EGFP-HCS Fusion Protein Capable of Specific Delivery Through the Blood-brain Barrier to the Central Nervous System
CNS & Neurological Disorders - Drug Targets Recombinant Antibody Fragments for Neurodegenerative Diseases
Current Neuropharmacology The Blood-Brain Barrier Choline Transporter
Central Nervous System Agents in Medicinal Chemistry Do Substance P and the NK1 Receptor have a Role in Depression and Anxiety?
Current Pharmaceutical Design Dopamine D1 Receptors, Regulation of Gene Expression in the Brain, and Neurodegeneration
CNS & Neurological Disorders - Drug Targets Biomaterial and Stem Cell Interactions: Histological Biocompatibility
Current Stem Cell Research & Therapy Determination of Lipoic Acid in the form of 2-S-pyridinium Derivative by High-performance Liquid Chromatography with Ultraviolet Detection
Current Analytical Chemistry Molecular Aspects of Modulation of L-type Calcium Channels by Protein Kinase C
Current Molecular Pharmacology